◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

RELMADA THERAPEUTICS, INC.

CIK: 1553643 SIC: 2834
-
Revenue
$-57.39M
Net Income
-
Gross Margin
-
Op. Margin
$-88.32M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 11 of 11 annual reports available (2013 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Jun 30, 2019)
FY 2018
(Jun 30, 2018)
FY 2017
(Jun 30, 2017)
FY 2015
(Jun 30, 2015)
FY 2013
(Aug 31, 2013)
+ Total Revenue - - - - - - - - - - - $5.13K
Revenue Growth % nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Cost of Revenue - - - - - - - - - - - $4.04K
+ Gross Profit - - - - - - - - - - - $1.09K
Gross Margin % nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% 21.3%
Operating Expenses $59.10M $59.10M $83.89M $103.70M $161.25M $125.70M $60.84M $12.73M $6.92M $7.22M $17.10M $46.11K
Research & Development $26.88M $26.88M $46.18M $54.81M $113.32M $90.62M $35.97M $7.02M $2.94M $1.29M $7.87M -
+ Operating Income $-59.10M $-59.10M $-83.89M $-103.70M $-161.25M $-125.70M $-60.84M $-12.73M $-6.92M $-7.22M $-17.10M $-45.02K
Operating Margin % nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% -877.7%
Interest Expense - - - - - - $2.42K $5.93K $2.56K $2.65K $4.92K -
Interest Income $1.40M $1.40M $3.53M $5.15M - - - - - - $10.88K -
Other Income/Expense $1.72M $1.72M $3.91M $4.91M $4.21M $-48.32K $1.38M $-4.59M $-2.04M $932.31K $-3.70M -
+ Net Income $-57.39M $-57.39M $-79.98M $-98.79M $-157.04M $-125.75M $-59.46M $-17.32M $-8.96M $-6.29M $-20.80M $-45.02K
Net Margin % nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan% -877.7%
Basic EPS nan -1.45 -2.65 -3.28 -5.30 -7.16 nan nan nan nan nan nan
Diluted EPS nan -1.45 -2.65 -3.28 -5.30 -7.16 nan nan nan nan nan nan
Basic Shares Outstanding 7.2M 39.5M 30.2M 30.1M 29.6M 17.6M - - - - - -
Diluted Shares Outstanding 7.2M 39.5M 30.2M 30.1M 29.6M 17.6M - - - - - -
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Jun 30, 2019)
FY 2018
(Jun 30, 2018)
FY 2017
(Jun 30, 2017)
FY 2015
(Jun 30, 2015)
FY 2013
(Aug 31, 2013)
Cash & Cash Equivalents $3.50M $3.86M $4.09M $5.40M $44.44M $2.50M $9.22M $2.24M $1.71M $22.47M $15.29K
Short-term Investments $89.51M $41.05M $92.23M $142.93M $167.47M $114.60M - - - - -
Accounts Receivable - - - $512.43K - - - - - - -
Total Current Assets $93.98M $45.80M $97.51M $152.87M $223.30M $118.07M $9.98M $2.74M $2.47M $23.97M $18.46K
Property Plant & Equipment - - - - - $1.26K $7.21K $12.08K $2.31K $23.91K $1.55K
Other Non-current Assets $19.50K $21.98K $43.12K $34.88K $28.29K $25.00K $25.00K $24.79K $21.96K - -
Total Assets $94.00M $45.82M $97.55M $152.91M $223.33M $118.19M $10.22M $3.05M $2.84M $24.39M $20.01K
Accounts Payable $1.57M $4.13M $3.51M $5.26M $11.19M $8.35M $924.36K $765.44K $529.56K $835.28K $33.67K
Accrued Liabilities $4.86M $6.16M $8.69M $7.21M $3.87M $4.26M $1.32M $659.46K $394.56K $482.27K -
Total Current Liabilities $6.43M $10.29M $12.19M $12.47M $15.06M $12.60M $2.61M $5.90M $1.38M $15.58M $33.67K
Total Liabilities $7.49M $10.30M $12.19M $12.47M $15.06M $12.60M $2.61M $8.56M $1.38M $15.58M -
Common Stock $73.33K $30.17K $30.10K $30.10K $27.74K $16.33K $38.98K $12.55K $12.53K $10.78K $28.50K
Retained Earnings $-698.27M $-640.88M $-560.90M $-462.11M $-305.07M $-179.32M $-111.66M $-94.34M $-85.38M $-76.12M -
Total Stockholders Equity $86.51M $35.52M $85.36M $140.44M $208.26M $105.58M $7.61M $-5.51M $1.46M $8.81M $-13.66K
Total Liabilities & Equity $94.00M $45.82M $97.55M $152.91M $223.33M $118.19M $10.22M $3.05M $2.84M $24.39M $20.01K
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Jun 30, 2019)
FY 2018
(Jun 30, 2018)
FY 2017
(Jun 30, 2017)
FY 2015
(Jun 30, 2015)
FY 2013
(Aug 31, 2013)
Net Income $-57.39M $-57.39M $-79.98M $-98.79M $-157.04M $-125.75M $-59.46M $-17.32M $-8.96M $-6.29M $-20.80M $-45.02K
Stock-based Compensation $26.31M $13.91M $30.18M $43.81M $44.19M $40.49M $20.78M $1.21M $518.00K $704.45K $796.95K -
Change in Receivables - - - - $512.43K - - - - - - -
Change in Inventory - - - - - - - - - - - $3.24K
Change in Payables $-8.20M $-2.56M $624.55K $-1.76M $421.04K $2.85M $7.82M $158.92K $157.39K $-730.15K $89.19K $20.40K
Operating Cash Flow $-88.32M $-45.79M $-51.76M $-51.66M $-103.80M $-91.87M $-27.81M $-10.50M $-6.00M $-6.47M $-16.23M $-11.86K
Capital Expenditure - - - - - - $182.05M - $12.39K $49.69K $23.33K $-1.80K
Purchases of Investments - - - - $47.29M $222.98M $182.05M - - - - -
Investing Cash Flow $-10.74M $-48.14M $51.56M $50.45M $19.73M $-54.12M $-34.45M - $-12.39K $-49.69K $-23.33K $-1.80K
Stock Issued - $93.64M - - $42.73M $184.64M $19.79M - - - - $20.00K
Financing Cash Flow - $93.56M $-40.34K $-98.46K $45.02M $187.94M $28.47M $17.48M $6.54M $-273.67K $13.16M $20.00K
Net Change in Cash - - - - - - - $6.98M $528.43K $-6.79M - -
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Operating Expenses $10.33M - $38.77M -
Research & Development $4.04M - $18.81M -
Operating Income $-10.33M - $-38.77M -
Interest Expense - - - -
Interest Income $247.01K - $1.01M -
Other Income/Expense $235.85K - $1.25M -
Net Income $-10.09M $-17.77M $-37.52M -
Basic EPS -0.30 - -1.16 -
Diluted EPS -0.30 - -1.16 -
Basic Shares Outstanding $33.19M - $32.27M -
Diluted Shares Outstanding $33.19M - $32.27M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $1.38M $3.86M
Short-term Investments $12.50M $41.05M
Total Current Assets $14.85M $45.80M
Other Non-current Assets $21.98K $21.98K
Total Assets $14.88M $45.82M
Accounts Payable $1.45M $4.13M
Accrued Liabilities $3.74M $6.16M
Total Current Liabilities $5.19M $10.29M
Total Liabilities $5.41M $10.30M
Common Stock $33.19K $30.17K
Retained Earnings $-678.40M $-640.88M
Total Stockholders Equity $9.47M $35.52M
Total Liabilities & Equity $14.88M $45.82M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-10.09M $-17.77M $-37.52M -
Stock-based Compensation - - $11.53M -
Change in Payables - - $-2.68M -
Operating Cash Flow - - $-31.19M -
Investing Cash Flow - - $28.79M -
Financing Cash Flow - - $-73.02K -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...